Menu

Side effects and common adverse reactions of Tarlatamab

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

While Tarlatamab is effective, it may also cause some side effects. These side effects have individual differences, and patients need to pay more attention.

Tarlatamab side effects that require immediate medical attention

While receiving Tarlatamab, seek immediate medical attention if:

Hives, difficulty breathing, swelling of the face, lips, tongue, or throat.

Side effects of Tarlatamab that require immediate consultation with your doctor

Tarlatamab may cause the following side effects. Please consult your doctor immediately if the following side effects occur:

1. Low blood cell count

Fever, chills, fatigue, mouth ulcers, skin ulcers, easy bruising, abnormal bleeding, pale skin, cold hands and feet, dizziness or shortness of breath.

2. Signs of infection

Fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding.

3. Symptoms of liver failure

Diarrhea, loss of appetite, stomach pain or swelling, leg swelling, easy bleeding, drowsiness, confusion, or jaundice (yellowing of the skin or eyes).

Tarlatamab (Tarlatamab) side effects for medical personnel to refer to

1. Immunity

Very common (10% or more): cytokine release syndrome (55%).

2. Musculoskeletal

Very common (10% or more): musculoskeletal pain (30%).

3. Metabolism

Very common (10% or more): hyponatremia (68%), decreased potassium (50%), decreased magnesium (33%), increased sodium (26%).

4. Urogenital

Very common (10% or more): urinary tract infection (10%).

5. Liver function

Very common (10% or more): Elevated liver enzymes: AST (44%), ALT (42%)

6. Respiratory system

(1) Very common (10%) or more): dyspnea (17%), cough (17%)

(2) Common (1% to 10%): pneumonia

7. Nervous system

Very common (10% or more): dysgeusia (36%).

8. Kidney function

Very common (10% or more): elevated creatinine (29%).

9. Gastrointestinal system

Very common (10% or more): nausea (22%), constipation (30%).

10. Others

Very common (10% or more): fatigue (51%), fever (36%), decreased appetite (34%), blood, anemia (27%), lymphopenia at all levels (84%), decreased hemoglobin (58%), leukopenia (44%), thrombocytopenia (33%), neutropenia (12%).

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。